Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1.16M
-
Shares change
-
-54.9K
-
Total reported value, excl. options
-
$626K
-
Value change
-
-$33.7K
-
Number of buys
-
3
-
Number of sells
-
-6
-
Price
-
$0.54
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q3 2024
18 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q3 2024.
HCW Biologics Inc. - COM (HCWB) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.16M shares
.
Largest 10 shareholders include Avantax Planning Partners, Inc. (280K shares), GEODE CAPITAL MANAGEMENT, LLC (183K shares), HighTower Advisors, LLC (181K shares), Cresset Asset Management, LLC (132K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (84.7K shares), Pullen Investment Management, LLC (75.1K shares), HRT FINANCIAL LP (46.5K shares), BlackRock, Inc. (44.3K shares), VANGUARD GROUP INC (37.7K shares), and AE Wealth Management LLC (30K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.